| Literature DB >> 30404599 |
Ling Ye1, Chuanbing Wen2, Hui Liu3.
Abstract
BACKGROUND: The purpose of this study was to investigate the feasibility, accuracy and efficiency of the facet joint injections in the lumbar spine by ultrasound guided versus lose dose computed tomography (CT) guidance.Entities:
Keywords: Accuracy; Computed tomography; Efficiency; Lumbar facet joint injection; Ultrasound
Mesh:
Year: 2018 PMID: 30404599 PMCID: PMC6223004 DOI: 10.1186/s12871-018-0620-7
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.217
Fig. 1The spinous processes of the lumbar spine demonstrated in a posterior paravertebral parasagittal sonogram. Arrow: spinous process (SP)
Fig. 2The lateral distance (a) defined as the horizontal distance from the middle point between the tips of the spinous processes to the reference point, the depth (b) defined as the vertical distance from the middle of the tip of the spinous process to the reference point, and the oblique line (c) defined as the distance from the middle point between the tips of the spinous processes to the reference point
Fig. 3Patient flow chart: randomization, treatment, and inclusion in analysis
Fig. 4The needle tip verified under the CT monitoring. SP: Spinous process; arrow: needle
A, B, C values of ultrasound and CT in the same spine level
| Ultrasound | CT | |||
|---|---|---|---|---|
| Left(cm) | right(cm) | left(cm) | right(cm) | |
| AL1/2 | 1.56 ± 0.19 | 1.54 ± 0.25 | 1.55 ± 0.21 | 1.51 ± 0.23 |
| BL1/2 | 2.17 ± 0.22 | 2.16 ± 0.28 | 2.17 ± 0.21 | 2.17 ± 0.32 |
| CL1/2 | 2.67 ± 0.26 | 2.66 ± 0.26 | 2.68 ± 0.25 | 2.65 ± 0.31 |
| AL2/3 | 1.54 ± 0.22 | 1.58 ± 0.28 | 1.51 ± 0.21 | 1.56 ± 0.26 |
| BL2/3 | 2.35 ± 0.25 | 2.39 ± 0.24 | 2.39 ± 0.26 | 2.41 ± 0.23 |
| CL2/3 | 2.84 ± 0.26 | 2.87 ± 0.26 | 2.85 ± 0.24 | 2.88 ± 0.24 |
| AL3/4 | 1.77 ± 0.32 | 1.79 ± 0.28 | 1.76 ± 0.32 | 1.82 ± 0.30 |
| BL3/4 | 2.46 ± 0.23 | 2.46 ± 0.24 | 2.49 ± 0.23 | 2.47 ± 0.22 |
| CL3/4 | 3.05 ± 0.23 | 3.05 ± 0.23 | 3.06 ± 0.23 | 3.08 ± 0.22 |
| AL4/5 | 1.97 ± 0.32 | 2.03 ± 0.32 | 1.97 ± 0.32 | 2.03 ± 0.32 |
| BL4/5 | 2.27 ± 0.37 | 2.29 ± 0.35 | 2.28 ± 0.42 | 2.30 ± 0.33 |
| CL4/5 | 3.06 ± 0.23 | 3.07 ± 0.33 | 3.08 ± 0.24 | 3.08 ± 0.31 |
| AL5S1 | 2.12 ± 0.35 | 2.15 ± 0.29 | 2.11 ± 0.37 | 2.16 ± 0.31 |
| BL5S1 | 2.21 ± 0.33 | 2.25 ± 0.23 | 2.22 ± 0.35 | 2.26 ± 0.27 |
| CL5S1 | 3.08 ± 0.26 | 3.09 ± 0.31 | 3.09 ± 0.26 | 3.15 ± 0.34 |
Demographic data of the two groups
| US group | CT group | P | |
|---|---|---|---|
| F/M | 9/11 | 12/8 | |
| Years | 55 ± 12.4 | 54.5 ± 14.4 | |
| Disease course (mon) | 52.6 ± 11.2 | 42.6 ± 5.2 | |
| BMI | 24.3 ± 0.80 | 24.7 ± 2.19 | |
| VAS | 7.00 ± 0.88 | 6.25 ± 2.31 |
F female, M male, BMI body mass index, VAS visual analog scale
Patients of remission rate ≥ 50% and VAS after procedures
| Remission rate | VAS | |||
|---|---|---|---|---|
| US group | CT group | US group | CT group | |
| 30 min | 14 | 14 | 2.95 ± 0.18 | 2.98 ± 0.21 |
| 1 day | 16 | 16 | 2.76 ± 0.14 | 2.98 ± 0.18 |
| 2 days | 16 | 16 | 2.81 ± 0.20 | 2.83 ± 0.17 |
| 6 weeks | 16 | 16 | 2.86 ± 0.15 | 2.84 ± 0.15 |